Back
NVO logo

Novo Nordisk A/S (NVO)

Pharmaceuticals
NVO · OMX NORDIC EXCHANGE COPENHAGEN A/S · DKK
New to investing? How to read this page →
kr49.28
−0.40%
Watch Compare

Weekly undervalued picks

Price · 1 year
Watch+ Add to portfolio
Loading live analysis…
Loading analysis…

Intrinsic Investor is for research and education only. Not financial advice.

Key metrics

EPS
$23.03
ROE
71.4%
Gross margin
83.2%
Debt/Equity
0.72x
Revenue growth
24.0%

AI Valuation Narrative

Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.

Screen StocksLearn Intrinsic ValueTrading SignalsCompare Stocks

Explore more

More in Pharmaceuticals →More in Drug Manufacturers - General →Stocks in DK →Stocks on OMX NORDIC EXCHANGE COPENHAGEN A/S →Compare stocks side-by-side →

Peers & similar stocks

Quick links to related tickers for research.

Eli Lilly and CoLLYJohnson & JohnsonJNJMerck & Company, Inc.MRKAstraZeneca PLCAZNPfizer, Inc.PFEBristol-Myers Squibb CompanyBMY

About Novo Nordisk A/S

 

Weekly undervalued picks

Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.

Free. No spam. We only email once per week.

Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.